Book a demo

Passive Insulated Pharma Shippers Patents: Leaders & White Space 2026

Passive Insulated Pharma Shippers Patents: Leaders & White Space 2026
https://www.patsnap.com/resources/blog/rd-blog/passive-insulated-pharmaceutical-shippers-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Pharmaceutical Cold Chain
Passive Insulated Pharmaceutical Shippers: Patents Behind the Cold Chain
  • Filing peaked in 2017 at 16 records and has fallen since, with 2021-to-2024 filings down -100% on the dataset's own comparison — though 2025-26 figures are still filling in given the ~18-month publication lag.
  • One assignee leads at 23 records against a fifth-place figure of 7 and a tenth-place figure of 2, out of 12 ranked companies — a steep drop-off rather than a gradual one.
  • B65D packaging claims dominate at 81.3% of the 75 records in scope, with F25D cooling claims close behind at 61.3% — most activity sits in container structure and thermal management, not adjacent mechanical or handling classes.
Get a prior-art report on your approach
75
Published Records
-100%
Filing Growth 2021→2024
US
Leading Jurisdiction
12
Active Filers Ranked

Filing growth compares 2021 (12 records) with 2024 (0) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this landscape covers

This landscape tracks patent activity for passive insulated pharmaceutical shippers — reusable or single-use containers that hold a payload within a defined temperature range for a set hold time without active power, typically using phase change material or vacuum insulated panels. The search spans records published between 2015 and mid-2026, filtered to documents that combine container or shipper terminology with the specific technical vocabulary of conditioning procedures, payload volume and reusable design.

The 75 records in scope sit predominantly in container and packaging classifications, with a secondary concentration in refrigeration and cooling apparatus. Filing activity is uneven year to year, and the most recent years understate true filing volume because publication lags filing by roughly 18 months.

Filing activity and technology composition, 2015-2026
  1. 1LAMINAR MEDICA23
  2. 2PELICAN BIOTHERMAL LLC14
  3. 3PACKAGING TECH GRP LLC10
  4. 4AMERICAN AEROGEL CORP8
  5. 5WILLIAMS ALTON7
  6. 6OTTER PRODUCTS LLC3
  7. 7SOFTBOX SYST LTD3
  8. 8TUMBER JAMES WILLIAM HOWARD3
  9. 9TURTLE BV3
  10. 10INTEGREON GLOBAL INC2
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The data

Filing trend and technology composition

Two views of the same 75-record dataset: how filing volume has moved year over year, and which IPC subclasses the claims fall into.

Filing trend, 2017-2026

Filings peaked at 16 in 2017 and declined thereafter; the dataset's own year-over-year comparison shows 2021's 12 filings falling to 0 by 2024, a -100% change over that three-year span. Treat 2025 and 2026 as incomplete rather than as evidence of a continued decline, since publication lag means recent filings have not yet all surfaced.

Filing trend, 2017-2026051015201620172018201920202021202220232024202502026Most recent year is partial — publication lag means later filings are not yet visible.

IPC subclass composition

B65D (containers and packaging) appears in 81.3% of the 75 records and F25D (refrigeration and cooling) in 61.3%, with B32B (layered products and laminates) a distant third at 29.3%. Because records can carry multiple classes, these shares sum to well over 100%; they show where claim language concentrates, not a partition of the field.

IPC subclass compositionB65D · Containers & packaging6181.3%F25D · Refrigerators & cooling4661.3%B32B · Layered products & laminates2229.3%B65B · Packaging & wrapping912.0%F16L · Pipes & pipe fittings56.7%F28D · Heat-exchange apparatus34.0%B23P · Metal working (general)22.7%B31B · Box & carton making22.7%Other34.0%

Shares are the percentage of the 75 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Passive Insulated Pharmaceutical Shippers with Eureka

This page is one run against one query. Ask Eureka your own question about passive insulated pharmaceutical shippers and every answer comes back with the patent numbers behind it.

Try Eureka
Key patents

Most-cited records and a representative filing

Representative filing
US20190241350A12019-08-08

Thermally insulated shipping container with layered articulating vacuum insulated panels

PELI BIOTHERMAL LLC

A kit from which a thermally insulated shipping container may be assembled, built from an outer shell and four flat-stock vacuum insulated panels, each with three articulating sections that fold into 3-dimensional C-shaped units. The panels form nestable pairs that line the lower and upper portions of the outer shell to create a fully enclosed insulated payload chamber.Filed by Peli Biothermal, published 2019-08-08 as US20190241350A1.

US20190241350A1 — patent drawing 1US20190241350A1 — patent drawing 2
View full record
Highest-cited records in this dataset
#Publication no.Patent titleCitations
1US20120248101A1Insulated shipping container systems, kits and methods171
2US8613202B2Insulated shipping container systems and methods thereof150
3US7681405B2Insulated shipping container systems and methods thereof148
4WO2017207974A1A thermally insulated container80
5US7849708B2Temperature controlled shipping using one or more smaller insulated containers inside a larger insulated cont…39
6US20060230778A1Insulated shipping container systems and methods thereof38
7US20160090227A1High efficiency bolt-on thermal insulating panel and thermally insulated shipping container employing such a …16
8US20080197139A1Temperature Controlled Shipping Using One or More Smaller Insulated Containers Inside a Larger Insulated Cont…16
9US20210139225A1Insulated shipping container13
10NL2018589AAn insulated shipping container for works of art13

Citation counts favour older records simply because they have had more time to be cited; read them as a signal of influence within this corpus, not as a ranking of current technical importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for a filing decision

Three read-outs from the dataset that matter more than the raw counts on their own.

Filing momentum
-100%, 2021 to 2024
year-over-year change

Filing has cooled from its 2017 peak

The 16-filing peak in 2017 was not sustained; the dataset shows 2021's 12 filings dropping to 0 by 2024, the last year that can be treated as complete. That points to a field where the core mechanical approaches were staked out early rather than one still in a filing race.

Recency caveat: 2025-26 counts will rise as publications catch up.
Concentration at the top
23 vs. 7 vs. 2
leader / fifth / tenth place

One assignee holds a clear lead

Across the 12 companies in the ranking, the leader's 23 records dwarf the fifth-place figure of 7 and the tenth-place figure of 2. That gap suggests a single portfolio worth diligence before filing anything that touches vacuum insulated panel or nested-panel geometry.

This is the entire ranked list the data endpoint returns, not a top-50 or top-100 cut.
Class concentration
81.3% B65D, 61.3% F25D
share of 75 records

Claims sit in container structure and cooling, not adjacent classes

The IPC composition is heavily weighted toward container/packaging (B65D) and refrigeration (F25D) classifications, with layered-materials claims (B32B) a distant third. Classes like heat-exchange apparatus (F28D) and box-making (B31B) appear in only a handful of records each.

Shares sum past 100% because records carry multiple IPC classes.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to passive insulated pharmaceutical shippers, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who holds the ground and where it is open

The ranked assignees show where portfolio depth already exists; the gaps below show where claim language is thin.

Portfolio leader
23 records
leader in the ranking

A single assignee leads the ranked field

The top-ranked company holds 23 records against a field of 12 ranked assignees, with the fifth-place company at 7 and the tenth at 2. That distribution is a steep drop-off rather than a gradual tail, so freedom-to-operate work should start with this portfolio.

Ranking counted in records, not families adjusted for jurisdiction overlap.
Recent activity
0 in the latest year
across ranked assignees

No ranked assignee shows recent-year filing momentum

The recent-year momentum figures show the ranked assignees, including the leader, at 0 filings in the latest year captured. Given the publication lag, this understates true activity, but it also means no single company is visibly accelerating right now.

Momentum reads should be revisited once 2025-26 publications catch up.
Co-filing pattern
3 shared records
strongest co-assignee pair

Co-assignment is rare and concentrated in one pair

The strongest co-assignee relationship in the dataset appears three times, between an individual inventor-assignee and a corporate partner. Beyond that pair, co-filing is not a notable pattern in this field — most records carry a single assignee.

Useful for identifying licensing or spin-out relationships worth tracing further.
🔍
Under-claimed sub-areas
Branches with thin IPC representation relative to the core container and cooling classes.
Heat-exchange apparatus (F28D) integrationReusable panel refurbishment methodsAutomated conditioning-procedure verificationModular box-and-carton assembly (B31B)Pipe-fitting-based coolant routing (F16L)
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
LAMINAR MEDICA0
PELICAN BIOTHERMAL LLC0
Packaging Technology Group LLC0
American Aerogel Corp0
WILLIAMS ALTON0
Otter Products LLC0
Softbox Systems Ltd0
TURTLE BV0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's next

Where to take this analysis

The dataset points to a field with an entrenched leader and thin recent filing — here is how to use that.

Map claims against the leader's portfolio

Before drafting around vacuum insulated panel or nested-panel geometry, check claim scope against the 23-record leading portfolio identified in the ranking.

Explore assignee portfolios in Eureka

Test white space in under-claimed classes

F28D heat-exchange integration and F16L coolant routing show low record counts relative to the core B65D and F25D classes — worth a targeted claim search before committing R&D there.

Run a white space search in Eureka

Revisit the trend once 2025-26 publications land

The apparent decline through 2024 is real in the dataset but the most recent two years are still incomplete; re-check filing momentum in a future pull.

Set a monitoring alert in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions on this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Passive Insulated Pharmaceutical Shippers covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Passive Insulated Pharmaceutical Shippers in depth with Eureka

Go past this page: query the whole passive insulated pharmaceutical shippers corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.